Sacubitril/valsartan versus enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active-controlled study

Autor: Joaquim Tomaz Filho, Marcel Jose A. da Costa, Maria-Janieire N. N. Alves, Kelly Thayane Souza Correa, Marcelo Rodrigues dos Santos, Francis Ribeiro de Souza, Caio Eduardo Novaes Pinto, Rosa Maria Rodrigues Pereira, Antonio Carlos Pereira Barretto, Guilherme Wesley Peixoto da Fonseca, Camila P. Jordão, Carlos Eduardo Negrão

Publikováno v: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP

Background Sacubitril/valsartan reduces mortality in patients with heart failure with reduced ejection fraction (HFrEF) when compared with enalapril. However, it is unknown the effect of both treatments on exercise capacity. We compared sacubitril/va

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15cee4d9f5163f018c62d1c099c102e4
https://pubmed.ncbi.nlm.nih.gov/33992607